About Kura Sushi USA, Inc. Kura Sushi USA, Inc. is a leading technology-enabled Japanese restaurant concept with 83 locations across 22 states and Washington DC. The Company offers guests a ...
Kura Oncology Inc. (NASDAQ:KURA) is one of the stocks that will double in 2026. On November 24, Barclays analyst Etzer Darout ...
Shares of sushi restaurant chain Kura Sushi (NASDAQ:KRUS) jumped 4.2% in the afternoon session after investors reacted to the company's ongoing expansion efforts, which included a new restaurant ...
An update from Kura Sushi, Inc. ( ($JP:2695) ) is now available. Kura Sushi, Inc. has announced a resolution to distribute dividends of surplus, ...
Kura Oncology's FDA-approved Komzifti and strong financials offer growth potential in the evolving AML market. Learn more about KURA stock here.
The FDA recently approved the first drug in a new class of leukemia medicines. Kura Oncology’s endeavor to follow that newly blazed regulatory trail is now infused with $330 million from a ...
KOMZIFTI (ziftomenib), the first and only once-daily oral menin inhibitor for adult patients with R/R AML with a susceptible NPM1 mutation who have no satisfactory alternative treatment options, has ...
On November 13, 2025, Kyowa Kirin and Kura Oncology announced that the FDA has granted full approval for KOMZIFTI (ziftomenib) as the first once-daily targeted therapy for adults with relapsed or ...
Panera Bread will close at Jordan Creek this summer. But, Kura Revolving Sushi Bar will replace it with Iowa's first conveyor ...